Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.11, 2001-11, pp. : 1111-1134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 75-92

Adis International

Access to resources Recommend Favorite

Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review

By Coukell A.J. Noble S. Faulds D.

PharmacoEconomics, Vol. 15, Iss. 4, 1999-04 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite

Docetaxel: A Review of its Use in Non-Small Cell Lung Cancer

By Comer A.M. Goa K.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 53-80

Adis International

Access to resources Recommend Favorite

Paclitaxel for non-small cell lung cancer

By Ramalingam Sakkaraiappan Belani Chandra P

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1771-1780

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer

By Baldwin Claudine M. Perry Caroline M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2279-2302

Adis International

Access to resources Recommend Favorite